{"organizations": [], "uuid": "9792f934f4074c4c2a466d0be1d32c7acf56b0f3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-ini/brief-miragen-therapeutics-announces-initiation-of-second-phase-1-clinical-trial-of-mrg-110-idUSASC09YIX", "country": "US", "domain_rank": 408, "title": "BRIEF-MiRagen Therapeutics Announces Initiation Of Second Phase 1 Clinical Trial Of MRG-110", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T14:19:00.000+03:00", "replies_count": 0, "uuid": "9792f934f4074c4c2a466d0be1d32c7acf56b0f3"}, "author": "", "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-ini/brief-miragen-therapeutics-announces-initiation-of-second-phase-1-clinical-trial-of-mrg-110-idUSASC09YIX", "ord_in_thread": 0, "title": "BRIEF-MiRagen Therapeutics Announces Initiation Of Second Phase 1 Clinical Trial Of MRG-110", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-miragen therapeutics", "sentiment": "negative"}, {"name": "brief-miragen therapeutics announces initiation of second phase", "sentiment": "negative"}, {"name": "therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1, 2018 / 11:21 AM / Updated 13 minutes ago BRIEF-MiRagen Therapeutics Announces Initiation Of Second Phase 1 Clinical Trial Of MRG-110 Reuters Staff 1 Min Read\nMay 1 (Reuters) - miRagen Therapeutics Inc:\n* MIRAGEN THERAPEUTICS ANNOUNCES INITIATION OF SECOND PHASE 1 CLINICAL TRIAL OF MRG-110 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-05-01T14:19:00.000+03:00", "crawled": "2018-05-01T14:43:51.008+03:00", "highlightTitle": ""}